Threat actors are operationalizing AI to scale and sustain malicious activity, accelerating tradecraft and increasing risk for defenders, as illustrated by recent activity from North Korean groups ...

With the expansion of ThreatLocker’s deny-by-default approach to the cloud and mobile announced Thursday, the cybersecurity vendor is addressing one of the biggest challenges faced by MSPs today, CEO ...

We're relaunching PerfAgents with a renewed focus on performance test orchestration-bringing load testing, real user ...

A phase 2a trial of NMD Pharma’s rare disease prospect ignaseclant has missed its primary endpoint. But, with patients improving on multiple secondary endpoints, the biotech is accelerating ...

Abstract: Today’s cloud native applications are often built using a service-oriented architecture supported by many microservices hosted using serverless Function-as-a-Service (FaaS) platforms. The ...

With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead toward regulatory filings for the novel HIV regimen. In Gilead's ...

Good morning, and welcome to the Agios Pharmaceuticals Investor Conference Call and Webcast. [Operator Instructions] Please be advised that this call is being recorded at Agios' request. I would now ...

Want to use artificial intelligence (AI) that maintains privacy and doesn’t need a lake full of water or industrial electricity generator to make an emojii? Apple has that. Stop to consider it: the ...

Ono Pharmaceutical’s EP4 antagonist hit the primary progression-free survival endpoint in a phase 2 trial in patients with gastric cancer. The biopharma evaluated the Bristol Myers Squibb-partnered ...

When I click on the hisory tab under test in an endpoint, I see history of all endpoint tests. Also, the button in the first column has no label and isn't obvious what it is. Finally, the invoke ...

INNSBRUCK, Austria, Sept. 22, 2025 /PRNewswire/ -- AV-Comparatives, the leading independent cybersecurity testing lab, today announced the results of its 2025 Endpoint Prevention and Response (EPR) ...